BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 202418)

  • 21. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against poliomyelitis and measles viruses in immunized and unimmunized children, Ghana 1976-78.
    Böttiger M; Litvinov S; Assaad F; Lundbeck H; Heller L; Beausoleil EG
    Bull World Health Organ; 1981; 59(5):729-36. PubMed ID: 6976234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine control of poliomyelitis in the 1980s.
    Sabin AB
    Yale J Biol Med; 1982; 55(3-4):383-9. PubMed ID: 7180028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Observations on children vaccinated orally with triple anti-poliomyelitis vaccine].
    Kocińska-Sypczyńska D
    Przegl Epidemiol; 1976; 30(1):53-8. PubMed ID: 179117
    [No Abstract]   [Full Text] [Related]  

  • 25. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
    Esteves K
    Bull World Health Organ; 1988; 66(6):739-46. PubMed ID: 3266113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
    Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
    Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
    Lamy ME; Cornu C; Desmyter J
    Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The spread of the wild Poliovirus in the rural environment, the case of the Adzopé health district, Côte d'Ivoire].
    Akoua-Koffi CG; Nekouressi G; Tieoulou L; Guillot S; Faye-Kette H; Ehouman A
    Bull Soc Pathol Exot; 2004 May; 97(2):87-90. PubMed ID: 15255346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine.
    Takatsu T; Tagaya I; Hirayama M
    Bull World Health Organ; 1973; 49(2):129-37. PubMed ID: 4545320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against poliomyelitis in economically underdeveloped countries.
    Sabin AB
    Bull World Health Organ; 1980; 58(1):141-57. PubMed ID: 6966544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Poliomyelitis in New Caledonia: epidemiological data, post-vaccinal seroconversion, prophylactic strategy].
    Louis JP; Panon G; Le Gonidec G
    Med Trop (Mars); 1985; 45(3):223-33. PubMed ID: 2999557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Booster effect of Sabin poliomyelitis vaccine.
    Teplý V; Srámová H; Svandová E
    Bull World Health Organ; 1976; 54(6):681-4. PubMed ID: 1088514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.